EAGLE ASSET MANAGEMENT INC - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 273 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$10,915,045
-3.8%
285,809
+3.7%
0.06%
+3.2%
Q2 2023$11,341,186
-9.1%
275,740
+26.9%
0.06%
-13.7%
Q1 2023$12,476,000
+64.5%
217,320
+59.6%
0.07%
+58.7%
Q4 2022$7,586,000
+29.1%
136,175
-1.8%
0.05%
+21.1%
Q3 2022$5,876,000
+16.0%
138,738
+48.0%
0.04%
+18.8%
Q2 2022$5,064,000
-16.1%
93,742
-0.2%
0.03%
+3.2%
Q1 2022$6,036,000
-11.2%
93,940
-5.5%
0.03%
+3.3%
Q4 2021$6,796,000
-58.5%
99,399
-58.4%
0.03%
-59.5%
Q3 2021$16,379,000
-21.2%
239,191
-21.5%
0.07%
-16.9%
Q2 2021$20,795,000
+1.0%
304,735
+0.8%
0.09%
-2.2%
Q1 2021$20,587,000
+15.9%
302,396
+10.5%
0.09%
-9.0%
Q4 2020$17,761,000
+9.9%
273,588
-21.4%
0.10%
+20.5%
Q3 2020$16,167,000
+3.6%
348,290
+3.7%
0.08%
-6.7%
Q2 2020$15,610,000
+16.5%
335,855
+12.0%
0.09%
+7.2%
Q1 2020$13,399,000
-11.4%
299,964
+15.6%
0.08%
+13.7%
Q4 2019$15,126,000
+15.6%
259,546
+19.2%
0.07%
+9.0%
Q3 2019$13,083,000
+5.7%
217,796
-1.7%
0.07%
+6.3%
Q2 2019$12,377,000
-1.6%
221,622
-1.8%
0.06%
-6.0%
Q1 2019$12,576,000
+24.3%
225,703
+0.6%
0.07%
+4.7%
Q4 2018$10,117,000
-28.5%
224,344
+4.4%
0.06%
-5.9%
Q3 2018$14,159,000
+29.6%
214,964
+26.7%
0.07%
+15.3%
Q2 2018$10,924,000
+22.1%
169,614
+4.9%
0.06%
+20.4%
Q1 2018$8,944,000
+13.3%
161,620
-0.9%
0.05%
+14.0%
Q4 2017$7,892,000
-3.2%
163,096
+1.4%
0.04%
-8.5%
Q3 2017$8,157,000
-90.9%
160,859
-90.2%
0.05%
-91.3%
Q2 2017$89,778,000
+79.8%
1,647,018
+39.0%
0.54%
+72.6%
Q1 2017$49,925,000
+16.9%
1,185,041
+138.0%
0.31%
+11.7%
Q4 2016$42,723,000
+774.4%
497,996
+741.3%
0.28%
+751.5%
Q3 2016$4,886,000
-16.7%
59,191
-19.5%
0.03%
-19.5%
Q2 2016$5,869,000
+22.7%
73,574
+3.6%
0.04%
+24.2%
Q1 2016$4,784,000
-16.9%
71,032
-16.4%
0.03%
-13.2%
Q4 2015$5,756,000
-45.2%
84,924
-51.9%
0.04%
+5.6%
Q3 2015$10,502,000
+75.2%
176,374
+98.2%
0.04%
+5.9%
Q2 2015$5,994,000
+89.7%
88,978
+73.6%
0.03%
+88.9%
Q1 2015$3,159,000
+0.8%
51,253
-11.3%
0.02%0.0%
Q4 2014$3,133,000
-54.8%
57,778
-58.6%
0.02%
-10.0%
Q3 2014$6,926,000
+109.4%
139,542
+98.5%
0.02%
+11.1%
Q2 2014$3,308,000
-0.7%
70,301
-2.9%
0.02%0.0%
Q1 2014$3,330,000
-62.1%
72,426
-60.6%
0.02%
-28.0%
Q4 2013$8,776,000
+137.9%
183,946
+99.0%
0.02%
+38.9%
Q3 2013$3,689,000
+7.7%
92,442
-1.2%
0.02%
-21.7%
Q2 2013$3,425,00093,5210.02%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q1 2022
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders